Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

325-336 of 2022 results
Page 28 of 169
Key Publications August 7, 2020

High-risk atherosclerosis and metabolic phenotype: The roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation.

Metab Syndr Relat Disord. 2020;18:176-185

Lechner K, McKenzie AL, Kränkel N, Von Schacky C, Worm N, Nixdorff U, Lechner B, Scherr J, Weingärtner O, Krauss RM
Ectopic Fat Inflammation Lipids/Lipoproteins
Key Publications August 5, 2020

Nonalcoholic fatty liver disease in 2020.

Gastroenterology. 2020;158:1849-1850

Miller VM
Ectopic Fat Lipids/Lipoproteins Prevention
Key Publications July 27, 2020

Metabolism of lipoprotein(a): new findings, implications and outstanding issues.

Curr Opin Lipidol. 2020;31:163-165

Chan DC, Watts GF
Cardiovascular Disease Lipids/Lipoproteins Metabolism
Key Publications July 27, 2020

Regulation of lipoprotein lipase-mediated lipolysis of triglycerides.

Curr Opin Lipidol. 2020;31:154-160

Basu D, Goldberg IJ
Cardiovascular Disease Lipids/Lipoproteins Metabolism
Key Publications July 24, 2020

Remnant lipoproteins: are they equal to or more atherogenic than LDL?

Curr Opin Lipidol. 2020;31:132-139

Salinas CAA, Chapman MJ
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications July 24, 2020

The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?

Curr Opin Lipidol. 2020;31:140-146

Reeskamp LF, Tromp TR, Stroes ESG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications July 24, 2020

Apolipoprotein C-II: the re-emergence of a forgotten factor.

Curr Opin Lipidol. 2020;31:147-153

Wolska A, Reimund M, Remaley AT
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications July 23, 2020

The impact of atherosclerotic risk factors on disease progression in patients with previously diagnosed nonobstructive coronary artery disease: factors affecting coronary artery disease progression.

Coron Artery Dis. 2020;31:365-371

Durmaz E, Ikitimur B, Karadag B, Barman HA, Atici A, Koca D, Raimoglu U, Karaca OF, Mutlu D, Ongen Z
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications July 23, 2020

Lipoprotein(a): Is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

Curr Opin Lipidol. 2020;31:125-131

Langsted A, Nordestgaard BG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications July 22, 2020

The dedicated "Lp(a) clinic": A concept whose time has arrived?

Atherosclerosis. 2020;300:1-9

Tsimikas S, Stroes ESG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications July 21, 2020

Targeting LDL cholesterol: Early treatment is key to population health.

Atherosclerosis. 2020;300:37-38

Stock J
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications July 20, 2020

Atherogenic dyslipoproteinemia and management of ASCVD: Will new indices untie the Gordian knot?

J Am Coll Cardiol. 2020;75:2136-2139

Watts GF, Chan DC
Cardiovascular Disease Epidemiology Lipids/Lipoproteins
of 169